Post-prandial post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes

Diabetic Medicine

Volumn 19, Issue 4, 2002, Pages 317-321

  Chase, H P ^a   Saib, S Z ^a   MacKenzie, T ^a   Hansen, M M ^a   Garg, S K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Bolus insulin; Post prandial glucose; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN LISPRO; ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BOLUS INJECTION; CALORIE; CARBOHYDRATE DIET; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIET RESTRICTION; DIETARY INTAKE; FEMALE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LIPID DIET; MALE; METHODOLOGY; OUTPATIENT DEPARTMENT; RANDOMIZED CONTROLLED TRIAL; TECHNIQUE; TIME; BLOOD; DRUG EFFECT; METABOLISM; POSTPRANDIAL STATE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 0036275361     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00685.x     Document Type: Article

References (28)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective six year study
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
4. The emerging role of postprandial hyperglycaemic spikes in the pathogenesis of diabetic complications
5. The postprandial state and the risk of atherosclerosis
6. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy
7. Postchallenge plasma glucose and glycemic spikes are more strongly associated with artherosclerosis than fasting glucose or HbA1c level
8. Hyperglycemia and cardiovascular disease in type 2 diabetes
9. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
10. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-Year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
11. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
12. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men
13. Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: Using the rapid acting insulin analogue [lys (B28), pro (B29)] human insulin
14. Pre-meal insulin analog insulin Lispro vs. Humulin® R insulin treatment in young subjects with type 1 diabetes
15. Postprandial insulin lispro: A new therapeutic option for type 1 diabetic patients
16. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic β-cell function
17. Improved mealtime treatment of diabetes mellitus using an insulin analogue
18. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus
19. Gastric emptying in diabetes: An overview
20. Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus
21. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus
22. Superior mesenteric artery blood flow and gastric emptying in humans and the differential effects of high fat and high carbohydrate meals
23. Impact of insulin lispro on HbA1c values in insulin pump users
24. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
25. Insulin lispro in CSII: Results of a double-blind crossover study
26. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial